ArticlePharmaceutics2024

Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells.

Paula Aldaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.